Pathogenesis and management of antiphospholipid syndrome

Michael Greaves

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Antiphospholipid syndrome [APS] is an acquired thrombophilia which is associated with morbidity and mortality from thrombosis and pregnancy failure. It is important to recognise the condition, as thrombosis may be preventable through administration of anticoagulant therapy, and management of pregnancy in APS demands close monitoring and a multidisciplinary approach.

APS may be a discrete disorder, or may occur against a background of another autoimmune disease, typically but not restricted to, systemic lupus erythematosus.
Original languageEnglish
Pages (from-to)s4-s9
Number of pages6
JournalThrombosis Research
Volume123
Issue numberSupplement 2
DOIs
Publication statusPublished - 2009

Fingerprint

Antiphospholipid Syndrome
Thrombosis
Pregnancy
Thrombophilia
Systemic Lupus Erythematosus
Anticoagulants
Autoimmune Diseases
Morbidity
Mortality
Therapeutics

Cite this

Pathogenesis and management of antiphospholipid syndrome. / Greaves, Michael.

In: Thrombosis Research, Vol. 123 , No. Supplement 2, 2009, p. s4-s9.

Research output: Contribution to journalArticle

Greaves, Michael. / Pathogenesis and management of antiphospholipid syndrome. In: Thrombosis Research. 2009 ; Vol. 123 , No. Supplement 2. pp. s4-s9.
@article{7605b2f98a314376bd367a5c08570ddc,
title = "Pathogenesis and management of antiphospholipid syndrome",
abstract = "Antiphospholipid syndrome [APS] is an acquired thrombophilia which is associated with morbidity and mortality from thrombosis and pregnancy failure. It is important to recognise the condition, as thrombosis may be preventable through administration of anticoagulant therapy, and management of pregnancy in APS demands close monitoring and a multidisciplinary approach.APS may be a discrete disorder, or may occur against a background of another autoimmune disease, typically but not restricted to, systemic lupus erythematosus.",
author = "Michael Greaves",
year = "2009",
doi = "10.1016/S0049-3848(09)70002-7",
language = "English",
volume = "123",
pages = "s4--s9",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "Supplement 2",

}

TY - JOUR

T1 - Pathogenesis and management of antiphospholipid syndrome

AU - Greaves, Michael

PY - 2009

Y1 - 2009

N2 - Antiphospholipid syndrome [APS] is an acquired thrombophilia which is associated with morbidity and mortality from thrombosis and pregnancy failure. It is important to recognise the condition, as thrombosis may be preventable through administration of anticoagulant therapy, and management of pregnancy in APS demands close monitoring and a multidisciplinary approach.APS may be a discrete disorder, or may occur against a background of another autoimmune disease, typically but not restricted to, systemic lupus erythematosus.

AB - Antiphospholipid syndrome [APS] is an acquired thrombophilia which is associated with morbidity and mortality from thrombosis and pregnancy failure. It is important to recognise the condition, as thrombosis may be preventable through administration of anticoagulant therapy, and management of pregnancy in APS demands close monitoring and a multidisciplinary approach.APS may be a discrete disorder, or may occur against a background of another autoimmune disease, typically but not restricted to, systemic lupus erythematosus.

U2 - 10.1016/S0049-3848(09)70002-7

DO - 10.1016/S0049-3848(09)70002-7

M3 - Article

VL - 123

SP - s4-s9

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - Supplement 2

ER -